GX-03 Phase 2 Program Widens to Cover Full Atopic Dermatitis Spectrum
The GX-03 Phase 2 program has expanded to cover the full atopic dermatitis spectrum, widening the candidate's mid-stage development across the disease's clinical range.
Topic
Topic
The GX-03 Phase 2 program has expanded to cover the full atopic dermatitis spectrum, widening the candidate's mid-stage development across the disease's clinical range.